Amgen, Wyeth start RADIUS trial second stage

AMGN and partner WYE began the second part of their 10,000-patient Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS) trial. In the trial's second stage, 5,000 patients will receiv...